Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session

Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.

Benzinga

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Benzinga Before The Bell: Alibaba's Delisting Concerns, Amgen's Potential $10.7B Tax Bill, Kenya Will Not Shut Facebook Services And Other Top Financial Stories Monday, August 1

CNBC

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.

Benzinga

Food expiration dates are broken — a microbiologist explains how to fix them

Avoiding unseen food hazards is the reason people often check the dates on food packaging.

Inverse

Not Even the FDA Trusts the FDA To Regulate Food Safety

The FDA has effectively thrown up its hands over its most important food-related role.

Reason

Getting monkeypox treatment is easier, but still daunting and confusing

Though doctors and advocates have helped speed up access to the antiviral pills – of which the U.S. has enough to treat 1.7 million people – health providers are few and forms are still required.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Recap Of Friday's Biotech Catalysts - End of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

Benzinga

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Fake COVID treatments are circulating. How to spot them and get real medication

CHARLOTTE, N.C. — As COVID-19 cases soar around the country, fake treatments continue to linger on the open market, posing a safety risk to those seeking medical care.

Tribune News Service

West Virginia v. EPA: Getting to Actual Delegation

The Court should assimilate the “major questions” doctrine of West Virginia v. EPA and its precedents—including Chevron and what came even before that—to an approach that asks whether Congress has made an actual delegation. Only this will serve the relevant separation-of-powers principle.

Reason

Man accused of selling bleach as Covid cure through Florida church is extradited to US

Mark Grenon, who runs a ‘non-religious church’, charged for selling toxic industrial bleach as Covid cure

The Independent UK

Summer boosters for people under 50 shelved in favor of updated boosters in the fall

The Biden administration is scrapping plans to offer COVID boosters for people under 50 this summer. Instead they will push for an earlier release of the next generation boosters in the fall.

WEKU

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Altria's $13B Juul investment has lost 95% of its value

Altria reports its nearly $13 billion investment in troubled vaping company Juul is worth 95% less than it originally paid

Axios

Dems fear red states banning abortion will zero in on birth control next

Democrats fear that red, anti-abortion states could restrict or even ban birth control.

Los Angeles Times

What the heck is Pink Sauce and why should anyone not on TikTok care? Let us explain

You may have seen a “Pink Sauce” headline in your social feeds sometime in the past week. Maybe you skipped over it, but now it’s hard to escape. The Pink Sauce situation is real, and chef Carly Pii is taking it very, very personally.

Chicago Sun-Times

Federal bill to legalize marijuana would help, not hurt, the illicit market

California’s experience shows why burdensome taxes and regulations, as in Sen. Chuck Schumer’s proposed bill, would drive consumers away from the legal pot market.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

US to distribute 786,000 additional monkeypox vaccine doses obtained from Danish plant

Biden government has come under criticism for delayed response to monkeypox outbreak

Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193 in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of 130.58…

Benzinga

EXCLUSIVE: SIGA Technologies CEO Says Company Is Prepared To Respond To Monkeypox Outbreak With TPOXX Stockpile Upon Approval

SIGA Technologies Inc (NASDAQ: SIGA) shares have rallied about 50% since the World Health Organization declared monkeypox a public health emergency of global concern.

Reason

We Don't Need a White House Monkeypox 'Coordinator.' We Just Need the Vaccines.

The feds botch another epidemic.

Benzinga

Medtronic Stock Keeps Ticking Forward

Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year. Medtronic is the world's largest medical device maker with a portfolio of glucose monitors, stents, insulin pumps, pacemakers, and catheters. It serves patients in over 150 countries.

The Independent UK

Pink Sauce creator claims viral sauce doesn’t need FDA approval and the internet responds accordingly

“What do you mean FDA approved?” said the chef behind the mysterious Pink Sauce

The Independent UK

US signs off on 800,000 more doses of monkeypox vaccine

Health regulators say nearly 800,000 doses of monkeypox vaccine will soon be available for U.S. distribution

1 … 188 189 190 191

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.